First-in-human results of an in-body tissue architecture-induced tissue-engineered vascular graft “Biotube” for application in distal bypass for chronic limb-threatening ischemia
Authors:
Open Access
- 31 July 2022
- journal article
- research article
- Published by Elsevier in Journal of Vascular Surgery Cases, Innovations and Techniques
- Vol. 8 (3) , 488-493
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Acute Phase Pilot Evaluation of Small Diameter Long iBTA Induced Vascular Graft “Biotube” in a Goat ModelEJVES Vascular Forum, 2022
- iBTA-Induced Biotube® Blood Vessels: 2020 UpdateKidney and Dialysis, 2021
- Initial 3-year results of first human use of an in-body tissue-engineered autologous “Biotube” vascular graft for hemodialysisThe Journal of Vascular Access, 2019
- Global vascular guidelines on the management of chronic limb-threatening ischemiaJournal of Vascular Surgery, 2019
- Development of long in vivo tissue-engineered “Biotube” vascular graftsBiomaterials, 2018
- A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemiaJournal of Vascular Surgery, 2018
- One year Rat Study of iBTA-induced “Microbiotube” Microvascular Grafts With an Ultra-Small Diameter of 0.6 mmEuropean Journal of Vascular and Endovascular Surgery, 2018
- Long‐term animal implantation study of biotube‐autologous small‐caliber vascular graft fabricated by in‐body tissue architectureJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2011
- Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Analysis of amputation free and overall survival by treatment receivedJournal of Vascular Surgery, 2010
- Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategyJournal of Vascular Surgery, 2010